Kanza Afzal, Nadia Gul, Khalid Mehmood, Sobia Jawwad, Bushra Iqbal
ABSTRACT
Objective: The study aims to determine the diagnostic accuracy of digital breast tomosynthesis in diagnosing malignant and benign lesions, keeping histopathology as the gold standard.
Study Design: Cross-sectional study.
Place and Duration of Study: The study was carried out at the Department of Diagnostic Radiology, POF Hospital, Wah Cantt, Pakistan over a period of six months from 11th July 2021 to 11th January 2022.
Methods: A total of 200 women presenting with suspicion of breast malignancy were selected consecutively from the outpatient department, and Digital Breast Tomosynthesis (DBT) was performed, followed by a biopsy of the specimen to confirm the findings on histopathology.
Results: The average age of the sample was 48.3 + 7.1 years, ranging between 35 and 60 years. Palpable breast lump was recorded in 44.5%, pain in 33%, and nipple discharge in 35.5%. Family history of breast Ca was present in 25.5. On Digital Breast Tomosynthesis (DBT), 58.5% of lesions were labeled as malignant, while 53.5% were labeled as malignant on follow-up histopathology. On applying the formulae for calculation, the sensitivity of DBT was found to be 86% and specificity 73.1%. The positive predictive value of the DBT is 78.6%, and the negative predictive value is 81.9%.
Conclusion: In conclusion, Digital Breast Tomosynthesis is a significantly sensitive and specific tool for detecting malignant breast lesions in women suspected of breast carcinoma.
Keywords: Architectural Distortion, Breast Carcinoma, Digital Breast Tomosynthesis.
How to cite this: Afzal K, Gul N, Mehmood K, Jawwad S, Iqbal B. Assessment of Diagnostic Accuracy of Digital Breast Tomosynthesis in Distinguishing Malignant and Benign Breast Lesions. Life and Science. 2024; 5(1): 3-8. doi: http://doi.org/10.37185/LnS.1.1.416
Read PDFLife and Science is recognized by Pakistan Medical and Dental Council (PM&DC), Islamabad, Pakistan
All the articles published in Life and Science are licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License